Comprehensive evaluation of plasma tau biomarkers for detecting and monitoring Alzheimer’s disease in a multicenter and multiethnic aging population
- 23 June 2025
- journal article
- Published by Springer Nature in Nature Aging
- Vol. 5 (8) , 1601-1618
Abstract
Over 20% of patients with Alzheimer's disease (AD) worlwide are Chinese, although the efficacy of existing blood-based measures of AD biomarkers is largely unknown in Asian cohorts. Here we explored how plasma tau biomarkers correlated with cross-sectional and longitudinal AD-related outcomes and their diagnostic performance in 1,085 participants from three independent studies, including two Chinese cohorts, Greater-Bay-Area Healthy Aging Brain Study (n = 425) and Huashan (n = 297), and the North American Alzheimer's Disease Neuroimaging Initiative cohort (n = 363). Plasma p-tau217 performed best in classifying Aβ-positron emission tomography (PET) and tau-PET positivity throughout the AD continuum and correlated with all AD-related outcomes. A two-cutoff approach suggested that participants with intermediate plasma p-tau217 levels experienced rapid accumulation of Aβ-PET and entorhinal tau-PET, as well as accelerated hypometabolism and cognitive decline. Increased plasma p-tau217 was also associated with rapid longitudinal changes in Aβ-PET, tau-PET and neurodegeneration. These results suggest that plasma p-tau217 is superior in detecting multiple aspects of AD-related pathological changes and tracking disease progression.Keywords
This publication has 72 references indexed in Scilit:
- Tau Kinetics in Neurons and the Human Central Nervous SystemNeuron, 2018
- High performance plasma amyloid-β biomarkers for Alzheimer’s diseaseNature, 2018
- Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's diseaseNeuroImage, 2017
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer DiseaseJAMA Neurology, 2017
- PET Imaging of Tau Deposition in the Aging Human BrainNeuron, 2016
- Measurement of Longitudinal β-Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value RatiosJournal of Nuclear Medicine, 2015
- pROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics, 2011
- Alzheimer's Disease Neuroimaging Initiative (ADNI)Neurology, 2010
- Quantification of Five Neuropsychological Approaches to Defining Mild Cognitive ImpairmentThe American Journal of Geriatric Psychiatry, 2009
- An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interestNeuroImage, 2006